Precision Neurology Market to Hit $70.63 Billion by 2035 as AI Segment Grows 24.5%
Updated
Updated · Precedence Research · May 28
Precision Neurology Market to Hit $70.63 Billion by 2035 as AI Segment Grows 24.5%
1 articles · Updated · Precedence Research · May 28
The market is projected to rise from $21.07 billion in 2026 to $70.63 billion by 2035, implying a 14.6% compound annual growth rate.
Nearly one in three people are affected by neurological conditions globally, and demand for earlier detection, biomarker research, genomics and data-driven care is driving adoption.
AI and machine-learning analytics are the fastest-growing technology segment at a 24.5% CAGR, while genomics held the largest 2025 share at 28%.
North America led with 41% of the market in 2025, but Asia-Pacific is forecast to expand fastest at a 19.8% CAGR as genomic-medicine infrastructure improves.
Alzheimer's disease was the largest therapeutic area at 30% in 2025, underscoring how precision diagnostics and targeted therapies are reshaping neurology and adjacent psychiatry care.
Will Asia's booming neurology market create affordable solutions or just mirror North America's high-cost model?
With advanced AI diagnostics emerging, how will the vast treatment gap for millions of epilepsy patients be closed?
As new tech predicts Alzheimer's risk years in advance, are we prepared for the ethical fallout?